home / stock / awkn:cc / awkn:cc quote
Last: | $1.34 |
---|---|
Change Percent: | 7.2% |
Open: | $1.29 |
Close: | $1.34 |
High: | $1.34 |
Low: | $1.28 |
Volume: | 20,501 |
Last Trade Date Time: | 05/06/2022 04:52:01 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.34 | $1.29 | $1.34 | $1.34 | $1.28 | 20,501 | 05-06-2022 |
$1.25 | $1.25 | $1.25 | $1.27 | $1.2 | 229,956 | 05-05-2022 |
$1.2 | $1.25 | $1.2 | $1.25 | $1.18 | 8,877 | 05-04-2022 |
$1.23 | $1.22 | $1.23 | $1.27 | $1.2 | 36,115 | 05-03-2022 |
$1.23 | $1.23 | $1.23 | $1.28 | $1.2 | 75,766 | 05-02-2022 |
$1.23 | $1.27 | $1.23 | $1.3 | $1.23 | 68,465 | 04-29-2022 |
$1.3 | $1.3 | $1.3 | $1.33 | $1.25 | 82,242 | 04-28-2022 |
$1.25 | $1.3 | $1.25 | $1.3 | $1.22 | 17,260 | 04-27-2022 |
$1.3 | $1.3 | $1.3 | $1.35 | $1.29 | 7,358 | 04-26-2022 |
$1.31 | $1.3 | $1.31 | $1.35 | $1.27 | 30,491 | 04-25-2022 |
$1.3 | $1.39 | $1.3 | $1.4 | $1.3 | 14,444 | 04-22-2022 |
$1.4 | $1.43 | $1.4 | $1.43 | $1.37 | 20,573 | 04-21-2022 |
$1.45 | $1.53 | $1.45 | $1.53 | $1.45 | 7,676 | 04-20-2022 |
$1.55 | $1.58 | $1.55 | $1.58 | $1.5 | 16,108 | 04-19-2022 |
$1.55 | $1.53 | $1.55 | $1.55 | $1.53 | 2,835 | 04-18-2022 |
$1.53 | $1.54 | $1.53 | $1.58 | $1.5 | 17,794 | 04-15-2022 |
$1.53 | $1.54 | $1.53 | $1.58 | $1.5 | 17,662 | 04-14-2022 |
$1.55 | $1.59 | $1.55 | $1.59 | $1.5 | 13,677 | 04-13-2022 |
$1.55 | $1.6 | $1.55 | $1.6 | $1.55 | 8,729 | 04-12-2022 |
$1.57 | $1.55 | $1.57 | $1.6 | $1.53 | 14,860 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
AWAKN LIFE SCIENCES CORP. Company Name:
AWKN:CC Stock Symbol:
AQNC Market:
Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or mor...
Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), is ...